Fixation of one new Standard Input Output Norms (SIONs) at SION A 3685 under Chemical and Allied Product (Product Code A)

## Policy Analysis Report: Notification of New Standard Input Output Norms (SION) A3685 **1. Executive Summary:** This report analyzes a Public Notice issued by the Directorate General of Foreign Trade (DGFT), Ministry of Commerce and Industry, Government of India, regarding the fixation of a new Standard Input Output Norms (SION) with Serial Number A3685. The core purpose of this notice is to define the permissible quantity of import items required for manufacturing a specific export product, Doxycycline 100 mg. Dispersible Tablets, within the Chemical and Allied Product Group. The key finding is the establishment of SION A3685, specifying the allowable import quantity of Doxycycline Monohydrate 106.13 mg. Tablets Eq. to Anhydrous Tablet U.S.PB.P for the export of Doxycycline 100 mg. Dispersible Tablets. **2. Introduction:** This report aims to provide a comprehensive overview of the Public Notice issued by the DGFT on April 24, 2025, regarding the notification of a new Standard Input Output Norms (SION) A3685. The analysis is based solely on the provided text of the Public Notice. **3. Policy Overview:** This is a *new* policy establishing a new SION. * **Core Objective(s):** The core objective, as stated in the Public Notice, is to fix and notify a new Standard Input Output Norms (SION) at SION A3685 under the Chemical and Allied Product Product Code A. **4. Background and Rationale:** Since this is a new policy (establishing a new SION), the likely problem/issue it addresses is the lack of a pre-defined Standard Input Output Norms for the specific export product, Doxycycline 100 mg. Dispersible Tablets. This absence could lead to inconsistencies in import entitlements for manufacturers and exporters of this product, potentially hindering smooth trade operations. Establishing a SION provides clarity and predictability. **5. Key Provisions / Changes:** As this is a *new policy*, this section details the main components and rules established by the provided text: * **Establishment of SION A3685:** The core provision is the formal establishment of a new SION with the serial number A3685. * **Product Definition:** The SION applies to the "Export Product" Doxycycline 100 mg. Dispersible Tablets. * **Import Allowance:** It defines the permissible import item and quantity allowed for the production of the export product: 1 unit of Doxycycline 100 mg. Dispersible Tablets allows import of 106.13 mg of Doxycycline Monohydrate Tablets Eq. to Anhydrous Tablet U.S.PB.P. **6. Target Audience and Stakeholders:** Based on the provided text, the directly affected stakeholders are: * Manufacturers and exporters of Doxycycline 100 mg. Dispersible Tablets. * Customs authorities responsible for import clearance. * Other entities involved in the foreign trade of chemical and allied products. **7. Implementation Aspects (Inferred):** * **Responsible agency/bodies:** The Directorate General of Foreign Trade (DGFT) is the responsible body for issuing and implementing this SION. Customs authorities will likely be involved in enforcing the SION during import procedures. * **Timelines or procedures:** The text does not specify any particular timelines or procedures beyond the immediate effect of the Public Notice on April 24, 2025. Existing import/export procedures would apply in conjunction with this new SION. **8. Expected Outcomes / Impact of Changes:** The likely intended outcomes based on the policy's provisions in the text are: * **Standardization of Import Entitlements:** The primary impact is to standardize the import entitlements for manufacturers exporting Doxycycline 100 mg. Dispersible Tablets. * **Clarity and Predictability:** It provides clarity and predictability to manufacturers regarding the allowable import quantities for producing the specified export product. * **Facilitation of Trade:** By defining clear norms, the SION aims to facilitate smoother trade operations and reduce potential disputes related to import entitlements. **9. Conclusion:** The Public Notice regarding the fixation of new SION A3685 is a significant development for the manufacturers and exporters of Doxycycline 100 mg. Dispersible Tablets. It establishes a clear and standardized norm for import entitlements, promoting transparency and predictability in foreign trade operations. This SION is an important tool for the industry, facilitating efficient import management and export competitiveness.

Key Entities Referenced